UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neutrophil-to-lymphocyte ratio is prognostic in recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan

Biomarkers in medicine, 2021-08, Vol.15 (11), p.851-859

2021

Volltextzugriff (PDF)

Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide

International journal of inflammation, 2020, Vol.2020 (2020), p.1-8

2020

Volltextzugriff (PDF)

Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases

Journal of bone oncology, 2019-04, Vol.15, p.100218, Article 100218

2019

Volltextzugriff (PDF)

Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy

International journal of radiation oncology, biology, physics, 2018-08, Vol.101 (5), p.1123-1132

2018

Volltextzugriff (PDF)

Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients

Journal of oncology, 2018-01, Vol.2018 (2018), p.1-9

2018

Volltextzugriff (PDF)

Patients with advanced cholangiocarcinoma benefit from chemotherapy if they are fit to receive it: single center experience

Journal of B.U. ON., 2011-07, Vol.16 (3), p.469

2011

Volltextzugriff (PDF)

Flare Phenomenon in Advanced Colorectal Cancer: Cessation of Bevacizumab after Predefined Cycles of Therapy may not Affect Outcome

Uluslararası hematologi-onkoloji dergisi, 2017-03, Vol.27 (1), p.53-59

Besen, Ali

2017

Volltextzugriff (PDF)

Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit?

Medical oncology (Northwood, London, England), 2015-02, Vol.32 (2), p.476-476, Article 18

2015

Volltextzugriff (PDF)

A patient-based study on the adherence of physicians to guidelines for the management of type 2 diabetes in Turkey

Diabetes research and clinical practice, 2012-10, Vol.98 (1), p.75-82

2012

Volltextzugriff (PDF)

Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients

PloS one, 2019-07, Vol.14 (7), p.e0218627

2019

Volltextzugriff (PDF)

Lack of Prognostic Significance of C-erbB-2 Expression in Low- and High- grade Astrocytomas

Asian Pacific journal of cancer prevention : APJCP, 2014, Vol.15 (3), p.1333-1337

2014

Volltextzugriff (PDF)

Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy

Canadian respiratory journal, 2024-06, Vol.2024 (1), p.2803044

2024

Volltextzugriff (PDF)

Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer

International journal of surgical oncology, 2024-09, Vol.2024 (1), p.2124006

2024

Volltextzugriff (PDF)

Letter to Editor: "The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Its Influencing Factors"

Ear, nose, & throat journal, 2024-04, p.1455613241249268-1455613241249268

2024

Volltextzugriff (PDF)

Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol

Journal of Immunology Research, 2020, Vol.2020 (2020), p.1-10

2020

Volltextzugriff (PDF)

Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide

Mediators of inflammation, 2020, Vol.2020 (2020), p.1-9

2020

Volltextzugriff (PDF)

Predicting Teeth Extraction after Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer Patients Using the Novel GLUCAR Index

Diagnostics (Basel), 2023-12, Vol.13 (23), p.3594

2023

Volltextzugriff (PDF)

Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck

Cancer chemotherapy and pharmacology, 2021-11, Vol.88 (5), p.805-812

2021

Volltextzugriff (PDF)

Comment on: Does the Planning Target Volume Correlate with Toxicity for Head and Neck Cancer Patients Undergoing Radiation? A Prospective Observational Study

Indian journal of surgical oncology, 2024-09, Vol.15 (Suppl 3), p.481-482

2024

Volltextzugriff (PDF)

Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy

Ear, nose, & throat journal, 2021-02, Vol.100 (2), p.NP69-NP76

2021

Volltextzugriff (PDF)

Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy

Gastroenterology research and practice, 2020, Vol.2020 (2020), p.1-8

2020

Volltextzugriff (PDF)

Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy

The International journal of biological markers, 2019-06, Vol.34 (2), p.139-147

2019

Volltextzugriff (PDF)

High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer

Discover. Oncology, 2023-12, Vol.14 (1), p.230-230, Article 230

2023

Volltextzugriff (PDF)

The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients

Tomography (Ann Arbor), 2024-01, Vol.10 (1), p.79-89

2024

Volltextzugriff (PDF)

Clinical assessment of HRD scoring in relation to PARPi response in terms of statistical guidance on reporting results for CDx tests evaluation

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17597-e17597

2023

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Englisch
(81)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Neutrophil-to-lymphocyte ratio is prognostic in recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan

Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide

Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases

Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy

Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients

Patients with advanced cholangiocarcinoma benefit from chemotherapy if they are fit to receive it: single center experience

Flare Phenomenon in Advanced Colorectal Cancer: Cessation of Bevacizumab after Predefined Cycles of Therapy may not Affect Outcome

Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit?

A patient-based study on the adherence of physicians to guidelines for the management of type 2 diabetes in Turkey

Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients

Lack of Prognostic Significance of C-erbB-2 Expression in Low- and High- grade Astrocytomas

Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy

Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer

Letter to Editor: "The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Its Influencing Factors"

Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol

Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide

Predicting Teeth Extraction after Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer Patients Using the Novel GLUCAR Index

Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck

Comment on: Does the Planning Target Volume Correlate with Toxicity for Head and Neck Cancer Patients Undergoing Radiation? A Prospective Observational Study

Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy

Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy

Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy

High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer

The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients

Clinical assessment of HRD scoring in relation to PARPi response in terms of statistical guidance on reporting results for CDx tests evaluation

Suchergebnisse filtern